￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Long-term safety assessment of maribavi/ytaizhi

2026-02-01 22:25:32

Check Details
Gefapixant Citrate Overdose Risk Assessment

2026-02-01 22:25:32

Check Details
Does Stiripentol fall into the category of prescription psychotropic drugs?

2026-02-01 22:25:32

Check Details
Inquiry on the domestic approval progress of Futibatinib

2026-02-01 22:25:32

Check Details
The listing status and dynamics of mitapivat-Pyrukynd on the market

2026-02-01 22:25:32

Check Details
Pegcetacoplan - Detailed explanation of precautions for Empaveli

2026-02-01 22:25:32

Check Details
Patients’ experience sharing on using maribavi/Yitazhi

2026-02-01 22:25:32

Check Details
Who is not suitable for taking aprocitentan and what are its contraindications?

2026-02-01 22:25:32

Check Details
Can Tilpotide/Tisiparatide (Mufenda) be stopped suddenly and what precautions should be taken after stopping the medicine

2026-02-01 22:25:32

Check Details
Description of the medical insurance process and reimbursement time points for pitobrutinib/pirtobrutinib

2026-02-01 22:25:32

Check Details
Risk analysis of whether talazoparib (Tazena) can be stopped at will after taking it

2026-02-01 22:25:32

Check Details
Whether Crizotinib has been included in critical illness insurance and reimbursement policies

2026-02-01 22:25:32

Check Details
Category
相关知识